Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-05-21

Clinical Trial Update: ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT) [NA]

View source ↗

Summary

This clinical trial update describes a multicenter study evaluating the timing of dosing for a combined ARB and calcium channel blocker regimen to manage ambula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angiotensin receptor blocker (ARB) (ARB)
  • Calcium channel blocker (CCB) (CCB)

Snippet

Sponsor: Acrobat Trial Group | Conditions: Hypertension and Atrial Fibrillation | NA | Status: UNKNOWN